T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Microsoft
MSFT
|
+$3.68B |
| 2 |
Pinterest
PINS
|
+$2.14B |
| 3 |
Zoom
ZM
|
+$2.05B |
| 4 |
T-Mobile US
TMUS
|
+$1.98B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.78B |
Top Sells
| 1 |
Alibaba
BABA
|
+$3.74B |
| 2 |
Caterpillar
CAT
|
+$1.25B |
| 3 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.24B |
| 4 |
Netflix
NFLX
|
+$1.22B |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$1.11B |
Sector Composition
| 1 | Technology | 24.62% |
| 2 | Healthcare | 16.07% |
| 3 | Consumer Discretionary | 15.3% |
| 4 | Communication Services | 13.46% |
| 5 | Financials | 12.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1376
FibroGen
FGEN
$48.6M
| $13.2M | ﹤0.01% |
19,859
-56,064
| -74% | -$37.3M |
|
1377
SiTime
SITM
$6.76B
| $13.1M | ﹤0.01% |
103,862
-18,543
| -15% | -$2.35M |
|
|
CMRX
1378
DELISTED
Chimerix, Inc.
CMRX
| $13.1M | ﹤0.01% |
1,632,612
-106,257
| -6% | -$850K |
|
1379
Stoke Therapeutics
STOK
$1.29B
| $13M | ﹤0.01% |
387,423
-235,769
| -38% | -$7.94M |
|
1380
Celldex Therapeutics
CLDX
$1.62B
| $13M | ﹤0.01% |
389,048
+56,818
| +17% | +$1.9M |
|
|
ISEE
1381
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $13M | ﹤0.01% |
2,052,740
-110,452
| -5% | -$697K |
|
1382
Tri Pointe Homes
TPH
$3.09B
| $12.7M | ﹤0.01% |
592,423
-1,695,056
| -74% | -$36.3M |
|
1383
Genpact
G
$7.41B
| $12.7M | ﹤0.01% |
278,975
+2,112
| +0.8% | +$95.9K |
|
1384
Bumble
BMBL
$710M
| $12.6M | ﹤0.01% |
218,622
+700
| +0.3% | +$40.3K |
|
|
SBT
1385
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $12.4M | ﹤0.01% |
2,733,300
-15,533
| -0.6% | -$70.7K |
|
1386
AMC Entertainment Holdings
AMC
$1.44B
| $12.4M | ﹤0.01% |
21,852
+8,791
| +67% | +$4.98M |
|
|
INFN
1387
DELISTED
Infinera Corporation Common Stock
INFN
| $12.3M | ﹤0.01% |
1,207,529
+61,716
| +5% | +$630K |
|
1388
Sixth Street Specialty
TSLX
$2.32B
| $12.3M | ﹤0.01% |
555,000
| – | – |
|
1389
Coterra Energy
CTRA
$18.6B
| $12.2M | ﹤0.01% |
696,527
-17,498
| -2% | -$306K |
|
1390
Vornado Realty Trust
VNO
$8.25B
| $12.1M | ﹤0.01% |
259,145
-1,722
| -0.7% | -$80.4K |
|
1391
ATAI Life Sciences
ATAI
$992M
| $12M | ﹤0.01% |
+650,000
| New | +$12M |
|
1392
Guidewire Software
GWRE
$21.3B
| $11.7M | ﹤0.01% |
104,128
-14,886
| -13% | -$1.68M |
|
|
PBCT
1393
DELISTED
People's United Financial Inc
PBCT
| $11.6M | ﹤0.01% |
678,044
+2,900
| +0.4% | +$49.7K |
|
1394
Kforce
KFRC
$567M
| $11.6M | ﹤0.01% |
184,621
+160,343
| +660% | +$10.1M |
|
1395
Invitation Homes
INVH
$18.5B
| $11.6M | ﹤0.01% |
309,854
-15,591
| -5% | -$581K |
|
1396
Leggett & Platt
LEG
$1.3B
| $11.5M | ﹤0.01% |
222,432
-4,490
| -2% | -$233K |
|
1397
Prelude Therapeutics
PRLD
$64M
| $11.5M | ﹤0.01% |
400,802
-22,189
| -5% | -$635K |
|
1398
Enanta Pharmaceuticals
ENTA
$177M
| $11.1M | ﹤0.01% |
252,782
-611,479
| -71% | -$26.9M |
|
1399
United Therapeutics
UTHR
$18.3B
| $11M | ﹤0.01% |
61,255
-292,869
| -83% | -$52.5M |
|
1400
ePlus
PLUS
$1.97B
| $11M | ﹤0.01% |
252,918
-316
| -0.1% | -$13.7K |
|